Clinical Trials Logo

Filter by:
NCT ID: NCT02234817 Not yet recruiting - Accidental Falls Clinical Trials

Improving Balance and Mobility in Older Veterans

SPIRE
Start date: January 2015
Phase: N/A
Study type: Interventional

Falls are dangerous leading to injuries and even death. The VA has made fall prevention a priority but effective programs only reduce falls by 30%. Tai Chi, a standing exercise program, has been effective at improving balance but may not prevent falls. Most falls occur during walking when an individual experiences a slip or a trip. Programs that focus on walking, stepping, and recovery from a slip may be more effective at fall reduction. This study will compare Tai Chi to the investigators new multimodal balance intervention (MMBI). MMBI focuses on standing balance, walking, stepping, strength training, and recovery from a slip. A multimodal program will most likely be more effective than Tai Chi at improving balance and preventing falls in older Veterans and the investigators will use the results of this study to develop a larger study on fall prevention in older Veterans.

NCT ID: NCT02219373 Not yet recruiting - Clinical trials for Pediatric Chronic Neuropathic Pain

Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness Study

Start date: August 2023
Phase: Phase 3
Study type: Interventional

Given the widespread use of anticonvulsants in the pediatric chronic pain population and the absence of scientific data supporting their use, the investigators propose a randomized, double blind, two group parallel design in which a broad group of children and adolescents with chronic neuropathic pain would be randomized to receive either Gabapentin or Oxcarbazepine. The Primary Aim of the Study is to assess the frequencies of successful treatment of pediatric patients with neuropathic pain treated with either Gabapentin or Oxcarbazepine. The Primary Hypotheses are as follows: Hypothesis I: Both Gabapentin and Oxcarbazepine will result in significant reduction in pain scores when compared to each patient's baseline. Hypothesis II: Patients who continue on active drug (Gabapentin or Oxcarbazepine) during the second phase of the trial will report greater pain reduction relative to baseline than patients who are randomized onto placebo at this randomization point. Secondary Aims of the Study are to compare groups treated initially with Gabapentin or Oxcarbazepine with regard to reduction in pain scores (both at rest and with evoked maneuvers), functional disability scores, tolerability, and measures of mood and cognitive functioning. Secondary Hypotheses are that Gabapentin and Oxcarbazepine differ in their effects on: 1. Pain scores at rest and with evoked maneuvers 2. Functional disability scores 3. Tolerability (frequencies of side-effects) 4. Depression and anxiety scales 5. Neuropsychological measures of cognitive processing speed, working memory, and attention.

NCT ID: NCT02217215 Not yet recruiting - Cervical Disease Clinical Trials

Initial Study With the CNDS Advanced Cervical Scan to Recalibrate Spectral Data for Use in Future Screening Studies

Spectral
Start date: August 2014
Phase: Phase 1
Study type: Observational

The purpose of this study is to evaluate whether fluorescence and reflectance spectroscopy can improve the ability to detect the presence of premalignant lesions on the cervix.

NCT ID: NCT02216682 Not yet recruiting - Postoperative Pain Clinical Trials

Assessing the Efficacy of Intravenous Acetaminophen Versus the Oral Formulation for Perioperative Pain Treatment

Start date: August 2014
Phase: N/A
Study type: Observational

To compare oral (PO) to intravenous (IV) acetaminophen with postoperative pain scores, and consumptions of opiates, among orthopedic surgery patients undergoing total knee replacement with spinal anesthesia. Our hypothesis is that IV acetaminophen patients will have improved analgesia, less opioid consumption, a lower percentage of patients rescuing, or a longer time to first rescue with IV acetaminophen. The investigators will compare the efficacies of oral and intravenous acetaminophen for postoperative pain control, and utilization of opiates as rescue agents.

NCT ID: NCT02214836 Not yet recruiting - Urolithiasis Clinical Trials

Ultrasound Imaging of Kidney Stones and Lithotripsy

Start date: October 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether new software processing of ultrasound images can improve detection and size determination of kidney stones.

NCT ID: NCT02214394 Not yet recruiting - Healthy Clinical Trials

Detection of Propofol in Exhaled Breath

Start date: August 2014
Phase: N/A
Study type: Interventional

This study involves the use of an experimental device which will measure how much propofol is present in your exhaled breath during surgery compared to how much is in your blood. The study results will look at whether the device is as accurate as conventional methods for measuring propofol levels during surgery.

NCT ID: NCT02213575 Not yet recruiting - Hypertension Clinical Trials

Study 3: Minocycline Decreases Microglia Activation

Start date: April 15, 2024
Phase: Phase 2
Study type: Interventional

This study is a mechanistic study that will enroll 9 subjects who are participating in NCT02133885 (which is designed to evaluate minocycline to test the hypothesis that minocycline treatment would produce antihypertensive effects in drug-resistant neurogenic hypertensive individuals) to test whether the antihypertensive effect of minocycline is associated with a decrease in activated microglia in central nervous system autonomic regions as evidenced by changes in PET and MRI imaging.

NCT ID: NCT02209389 Not yet recruiting - Breast Cancer Clinical Trials

OctavaPink for Women With Dense Breast After Negative Mammography

Start date: August 2014
Phase: N/A
Study type: Observational [Patient Registry]

The OctavaPink test is indicated as an adjunct to mammography for breast cancer screening in asymptomatic women for whom screening or diagnostic mammography findings are normal or benign (BIRADS assessment category 1 or 2) and breast tissue is dense (BIRADS composition/density 3 or 4). The device is intended to increase breast cancer detection in the described patient population. Based upon the result of OctavaPink, the patient will be further evaluated by their physician.

NCT ID: NCT02205086 Not yet recruiting - Rheumatology Clinical Trials

Empowering Physicians With Evidence-Based Decision Support for Pediatric Rheumatology

Rheumatology
Start date: August 2014
Phase: N/A
Study type: Interventional

This study compares the ability of clinicians to make diagnoses with or without the assistance of diagnostic decision support software. The area of clinical focus is primarily rheumatology.

NCT ID: NCT02200718 Not yet recruiting - Multiple Sclerosis Clinical Trials

A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

Start date: December 31, 2020
Phase: Phase 1
Study type: Interventional

A Phase I Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis to demonstrate safety & efficacy